ATE91625T1 - Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren. - Google Patents

Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.

Info

Publication number
ATE91625T1
ATE91625T1 AT86105954T AT86105954T ATE91625T1 AT E91625 T1 ATE91625 T1 AT E91625T1 AT 86105954 T AT86105954 T AT 86105954T AT 86105954 T AT86105954 T AT 86105954T AT E91625 T1 ATE91625 T1 AT E91625T1
Authority
AT
Austria
Prior art keywords
detection
treatment
tumors
porphyrin derivatives
pharmaceutically acceptable
Prior art date
Application number
AT86105954T
Other languages
English (en)
Inventor
Jerry C Bommer
Bruce F Burnham
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Application granted granted Critical
Publication of ATE91625T1 publication Critical patent/ATE91625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86105954T 1985-04-30 1986-04-30 Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren. ATE91625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72878685A 1985-04-30 1985-04-30
EP86105954A EP0210351B1 (de) 1985-04-30 1986-04-30 Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren

Publications (1)

Publication Number Publication Date
ATE91625T1 true ATE91625T1 (de) 1993-08-15

Family

ID=24928279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86105954T ATE91625T1 (de) 1985-04-30 1986-04-30 Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.

Country Status (8)

Country Link
EP (1) EP0210351B1 (de)
JP (1) JPH0764728B2 (de)
AT (1) ATE91625T1 (de)
AU (1) AU589957B2 (de)
CA (1) CA1291710C (de)
DE (1) DE3688721T2 (de)
DK (1) DK168690B1 (de)
NO (1) NO173319C (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
JPS63192718A (ja) * 1987-02-06 1988-08-10 Hamari Yakuhin Kogyo Kk 肝障害抑制剤
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
PL317192A1 (en) * 1994-05-13 1997-03-17 Monsanto Co Methods of using pernitrite decomposition catalyst and their pharmaceutic compositions
EP1339862B1 (de) 2000-11-29 2014-01-08 PCI Biotech AS Photochemische internalisierung bei virus-vermittelter einführung von molekülen in das cytosol
HU229805B1 (en) 2000-11-29 2014-07-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
JP2011518891A (ja) * 2009-04-29 2011-06-30 ドイアテクフ コリア シーオー．，エルティーディー． クロリンｅ６−葉酸結合化合物およびキトサンを含有する癌治療用薬学的組成物
RU2537759C1 (ru) * 2013-07-12 2015-01-10 Евгений Валерьевич Жаров Способ фотодинамической терапии онкологических заболеваний
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
RU2604388C2 (ru) * 2015-04-29 2016-12-10 Евгений Владимирович Давыдов Флуоресцентная диагностика злокачественного новообразования животного

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819644B2 (ja) 1975-03-13 1983-04-19 ウェルファイド株式会社 スイチユウボウオザイ
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS57185220A (en) * 1981-05-07 1982-11-15 Yakult Honsha Co Ltd Carcinostatic agent containing chlorophyll derivative as active component
JPS58981A (ja) * 1981-06-26 1983-01-06 Tama Seikagaku Kk 水溶性ポルフイリン誘導体
US4614190A (en) 1981-09-08 1986-09-30 Alexei Stanco Photoradiation method and arrangement
DE3381616D1 (de) * 1982-09-27 1990-07-05 Photofrin Medical Inc Gereinigte hemaf 3381400inabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
AU589957B2 (en) 1989-10-26
CA1291710C (en) 1991-11-05
EP0210351A2 (de) 1987-02-04
JPH0764728B2 (ja) 1995-07-12
NO173319B (no) 1993-08-23
DK197286A (da) 1987-01-23
NO861724L (no) 1986-10-31
DK168690B1 (da) 1994-05-24
NO173319C (no) 1993-12-01
DE3688721D1 (de) 1993-08-26
DE3688721T2 (de) 1993-12-16
JPS625912A (ja) 1987-01-12
EP0210351B1 (de) 1993-07-21
DK197286D0 (da) 1986-04-30
AU5689186A (en) 1986-11-06
EP0210351A3 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
DE3688721D1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
DE69021530D1 (de) Neue Derivate von A-nor-3-Carboxysteroiden.
DE3650772D1 (de) Derivate von Indazole-3-carboxamide und -3-carboxylsäure
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ATE64379T1 (de) Derivate von n-(methylsulfonylphenylaethyl)-2propenamiden, und deren verwendung als antibiotika.
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
ATE91418T1 (de) Mittel zur behandlung der herzinsuffizienz.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO865245D0 (no) Fremgangsmaate for efterbehandling av jernsmelter.
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
ATE115857T1 (de) Verwendung von benzimidazolin-2-oxo-1- carbonsäurederivaten bei der behandlung organischer gehirnerkrankungen.
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
ATE65396T1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties